Anti-ALK7 antibodies (Acceleron Pharma)

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameAnti-ALK7 antibodies (Acceleron Pharma)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionActivin receptor type-1C inhibitors
TargetsActivin receptor type-1C
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcceleron Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcceleron Pharma Inc
Inactive CompaniesN/A
Active IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A